Lab
Esoterix Genetic Laboratories, LLC
Esoterix Genetic Laboratories, LLC was paid $724K by Medicaid between Jan 2018 and Sep 2024, across 28 billing codes. Its largest line is 88185, — 37% of everything it billed.
33Billing provider infoESOTERIX GENETIC LABORATORIES, LLC
NEW YORK, NY 10019
NEW YORK, NY 10019
33aNPI1659672004assigned 11/16/2010
33bProvider typeClinical Medical Laboratory
28Total paid$724K
24GClaims11,430
24DCodes billed28
24AFirst – last monthJan 2018 – Sep 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in New York
Rank by total paid#57 of 116
Median peer was paid$618K
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,679 | $513K | |
| 2019 | 1,063 | $61K | |
| 2020 | 820 | $63K | |
| 2021 | 1,026 | $33K | |
| 2022 | 274 | $4K | |
| 2023 | 479 | $48K | |
| 2024incomplete | 89 | $2K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88185 | 37% | 980 | 885 | $270K | |
| 88341 | 11% | 1,023 | 793 | $80K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 8.9% | 157 | 146 | $65K |
| 88189 | 8.2% | 2,522 | 2,296 | $60K | |
| 88342 | 5.5% | 1,713 | 1,540 | $40K | |
| 88360 | 4.8% | 958 | 791 | $35K | |
| 88184 | 3.5% | 983 | 896 | $26K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.2% | 349 | 253 | $23K |
| 88271 | 2.4% | 356 | 319 | $17K | |
| 88275 | 2.1% | 312 | 286 | $15K | |
| 81329 | 1.9% | 204 | 191 | $14K | |
| 88377 | 1.8% | 222 | 182 | $13K |
16 more codes
| 88365 | 1.7% | 265 | $12K | |
| 88264 | 1.5% | 153 | $11K | |
| 88237 | 1.4% | 147 | $10K | |
| 88364 | 1.3% | 171 | $10K | |
| 81206 | <1% | 121 | $7K | |
| 81207 | <1% | 121 | $6K | |
| 88323 | <1% | 153 | $4K | |
| 88313 | <1% | 145 | $3K | |
| 88321 | <1% | 147 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 115 | $1K |
| 81270 | <1% | 27 | $769.30 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 35 | $732.98 |
| 81243 | <1% | 14 | $627.44 | |
| 88188 | <1% | 12 | $515.45 | |
| 85097 | <1% | 12 | $387.36 | |
| 88182 | <1% | 13 | $385.22 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILLIAMS, KIMBERLY (VP)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.